Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Intco Medical Technology Co., Ltd.
  6. Summary
    300677   CNE100003456

INTCO MEDICAL TECHNOLOGY CO., LTD.

(300677)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
63.73 61.85 59.01 58.44 56 Last
16682610 16105050 19024650 9585981 13468560 Volume
-0.19% -2.95% -4.59% -0.97% -4.18% Change
Estimated financial data (e)
Sales 2021 21 860 M 3 456 M 3 456 M
Net income 2021 8 638 M 1 366 M 1 366 M
Net Debt 2021 - - -
P/E ratio 2021 3,56x
Yield 2021 4,76%
Sales 2022 19 255 M 3 044 M 3 044 M
Net income 2022 4 041 M 639 M 639 M
Net Debt 2022 - - -
P/E ratio 2022 7,62x
Yield 2022 2,83%
Capitalization 30 800 M 4 869 M 4 869 M
Capi. / Sales 2021 1,41x
Capi. / Sales 2022 1,60x
Nbr of Employees 6 503
Free-Float 61,3%
More Financials
Company
SHANDONG INTCO MEDICAL PRODUCTS CO., LTD. is a China-based company principally engaged in the research and development, manufacturing and sales of research and development, production and sales of medical care products. The Company's main products include medical care products, rehabilitation care products, health care products and inspection supplies, such as disposable gloves, wheelchairs, hot and cold compresses... 
More about the company
Ratings of Intco Medical Technology Co., Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about INTCO MEDICAL TECHNOLOGY CO., LTD.
2021Intco Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended S..
CI
2021Intco Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended Jun..
CI
2021INTCO MEDICAL TECHNOLOGY : to List 1.4 Million Restricted Shares
MT
2021Intco Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended..
CI
2021Intco Medical Technology Co., Ltd. Approves Profit Distribution Proposal for 2020, Paya..
CI
2021Intco Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2020
CI
2021Intco Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended Dec..
CI
2021INTCO MEDICAL (300677 : CH) Announced Record High Net Profit with Planned H-share Listing ..
AQ
2021Intco Medical Technology Co., Ltd. announced that it has received CNY 499.999981 millio..
CI
2020INTCO MEDICAL TECHNOLOGY CO., LTD.(S : 300677) added to Shenzhen Stock Exchange Component ..
CI
2020INTCO MEDICAL TECHNOLOGY CO., LTD.(S : 300677) added to Shenzhen Stock Exchange Component ..
CI
2020Intco Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended S..
CI
2020Intco Medical Technology Co., Ltd. Approves 2020 Interim Profit Distribution Plan, Paya..
CI
2020INTCO MEDICAL TECHNOLOGY CO., LTD.(X : 300677) added to S&P Global BMI Index
CI
2020INTCO MEDICAL TECHNOLOGY CO., LTD.(X : 300677) added to FTSE All-World Index
CI
More news
News in other languages on INTCO MEDICAL TECHNOLOGY CO., LTD.
2021Intco Medical Technology listera 1,4 million d'actions à négociation restreinte
2021Intco Medical Technology Co., Ltd. approuve la proposition de distribution des bénéfice..
2021Intco Medical Technology Co., Ltd. annonce une proposition de distribution des bénéfice..
2020Intco Medical Technology Co., Ltd. approuve le plan de distribution des bénéfices intér..
2020Intco Medical Technology Co., Ltd. propose un dividende en espèces pour le premier seme..
More news
Chart INTCO MEDICAL TECHNOLOGY CO., LTD.
Duration : Period :
Intco Medical Technology Co., Ltd. Technical Analysis Chart | 300677 | CNE100003456 | MarketScreener
Technical analysis trends INTCO MEDICAL TECHNOLOGY CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 56,00 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Qiong Chen General Manager & Executive Director
Jie Feng Manager-Finance Department
Fang Yi Liu Chairman
De Gang Zheng Manager-Human Resources
Yu Shen Ma Independent Director